| Metric | 25 Jan 2026 | 08 Feb 2026 | 22 Mar 2026 | Change |
|---|---|---|---|---|
| Weight | 84.9 kg | 84.6 kg | 80.8 kg | ↓ 3.8 kg ✓ |
| Body Fat % | 39.40% | 38.10% | 38.40% | ↑ 0.3% ⚠ |
| Fat Mass | 33.40 kg | 32.20 kg | 31.00 kg | ↓ 2.40 kg ✓ |
| Muscle Mass | 48.90 kg | 49.70 kg | 47.30 kg | ↓ 2.40 kg ⚠ |
| Fat-Free Mass | 51.50 kg | 52.40 kg | 49.80 kg | ↓ 1.70 kg ⚠ |
| BMI | 31.90 | 31.80 | 30.40 | ↓ 1.50 ✓ |
| Metabolic Age | 65 | 61 | 62 | ↓ 3 years ✓ |
| BMR | 1,557 kcal | 1,575 kcal | 1,502 kcal | ↓ 55 kcal ⚠ |
| Visceral Fat | 10 | 9 | 9 | ↓ 1 ✓ |
| Body Water | 42.60% | 42.30% | 41.80% | ↓ 0.80% ⚠ |
| Bone Mass | 2.60 kg | 2.70 kg | 2.50 kg | ↓ 0.10 kg ⚠ |
| Protein | 12.73 kg | 13.91 kg | 13.53 kg | ↑ 0.80 kg ✓ |
A metabolic age of 62 vs chronological 54 means your body is metabolising like someone 8 years older. The increase from 61 is driven by muscle loss reducing your metabolic rate. With resistance training and protein optimisation, this gap can close rapidly.
47.3 kg is still well above average for your age, but down from the 85th percentile last scan. The 2.4 kg loss has moved you from "exceptional" to "very good". This underlines why we must prioritise muscle preservation now — further loss would materially reduce your metabolic rate and strength.
At 38.4%, body fat remains above the desirable range of 24–36%. Despite losing 1.2 kg of fat mass, the percentage slightly increased because muscle loss outpaced fat loss. Correcting this ratio is the priority for the next 6 weeks.
A rating of 9 remains within the healthy range (1–12) and unchanged from last scan. This is positive — your internal organ fat is well controlled. Your sarcoidosis treatment and renal considerations make keeping this low especially important.
At 30.4 (Obese Class I — just barely), this has improved from 31.8. You're only 0.4 points away from the overweight category. At this rate of weight loss, you could be in the overweight category within weeks. Reaching 67 kg target would bring BMI to ~25.2.
2.5 kg is still acceptable but has dropped 0.2 kg from 2.7 kg. Given your prednisolone use, bone density protection is essential. Weight-bearing exercise, adequate calcium/vitamin D intake, and your Evorel patches all help protect bone. We should monitor this closely.
The 2.4 kg muscle loss between scans is the most important finding this month. You've lost more muscle (2.4 kg) than fat (1.2 kg) — the opposite of what we want. Research from leading longevity physicians shows that muscle mass after 50 is one of the strongest predictors of lifespan and quality of life. At 54, you have what's called anabolic resistance — your muscles need a higher protein stimulus to maintain themselves. You need 40–50g of protein per meal (not 20g), across 3–4 meals daily, totalling 130–160g. Adding 5g daily creatine and a casein protein shake before bed are two immediate, evidence-backed interventions. Resistance training minimum 2–3x per week is non-negotiable to preserve the fast-twitch muscle fibres that protect against falls and keep your metabolism running.
Your metabolic age increased from 61 to 62 despite losing 3.8 kg. This happens because muscle is metabolically active tissue — every kg lost reduces your basal metabolic rate. Your BMR dropped from 1,575 to 1,502 kcal, creating a vicious cycle: lower BMR → fewer calories needed → harder to lose fat → more restriction → more muscle loss. The science is clear: resistance training is the only intervention that reverses this. It's not just about size — it rebuilds muscle quality, which research shows declines significantly through menopause even when size is maintained. The Ultrahuman Ring can track your metabolic response to exercise and sleep, giving us real-time data to optimise your recovery.
Let's be clear: losing 4.1 kg from baseline (84.9 → 80.8 kg) in under 2 months is excellent progress. Your BMI has dropped from the mid-obese range to barely above the overweight threshold. The rate of weight loss is healthy and sustainable. We just need to refine the composition of that loss. The trajectory is right — we're fine-tuning the approach, not changing direction.
Your sarcoidosis history, kidney function at 60%, and current medications (prednisolone, methotrexate, bisoprolol) all influence how we approach training. The bone mass drop of 0.2 kg needs monitoring given prednisolone use. Low-impact resistance training protects joints while preserving muscle. Your fatigue and exercise intolerance mean we need smart programming — shorter, more effective sessions with compound movements.
Your Evorel patches, Utrogestan, and Vagifem address hormonal changes, while Mounjaro targets appetite and insulin sensitivity. This combination is clearly working for weight loss. However, clinical evidence shows that muscle quality changes significantly through menopause — even in women who maintain muscle size. Fat infiltrates the muscle tissue, reducing its metabolic effectiveness. Your HRT helps protect bone density (critical given the 0.2 kg drop), and Mounjaro supports fat loss — but without resistance training and adequate protein, the muscle quality decline continues unchecked. The three pillars must work together: HRT (hormonal protection) + Mounjaro (fat loss) + resistance training & protein (muscle preservation).
Despite elevated overall body fat, your visceral fat rating remains at a healthy 9 — unchanged from last scan. This means your fat is predominantly subcutaneous (under the skin) rather than around your organs. Subcutaneous fat responds very well to GLP-1 medication and lifestyle changes. This is genuinely good news for your metabolic health outlook and long-term cardiovascular risk profile.
Caroline, this scan shows a clear split story. The weight loss is excellent — 4.1 kg down from baseline with BMI dropping to 30.4, just above the overweight threshold. But the composition of that loss needs correcting: too much muscle has been lost alongside the fat, which has actually pushed your metabolic age up despite the weight coming down. Your visceral fat is healthy, but body fat %, bone mass and metabolic age have all gone the wrong way. The good news? This is a known and fixable pattern. With structured resistance training and optimised protein intake, we can shift the ratio firmly towards fat loss while protecting your muscle. A B grade within 4–5 months is achievable if we act now.
Start structured resistance training minimum 2–3x per week. Focus on compound movements (squats, modified deadlifts, rows, presses) in the 6–15 rep range. Increase protein to 130–160g daily across 4 meals (40g+ per meal to overcome anabolic resistance), with a casein shake before bed for overnight muscle repair. Start creatine (5g daily), vitamin D3 (4,000 IU) + K2, and omega-3 (2–4g EPA/DHA). Continue Mounjaro — the weight loss is working, we’re adding the muscle protection layer on top.
Continue Mounjaro at current dose. Establish consistent resistance training habit. Repeat body composition scan at 6 weeks to verify muscle preservation. Monitor protein intake with food diary. Blood tests to check kidney function (important given prednisolone and high protein), vitamin D, calcium, and bone markers. Target: lose fat while muscle holds steady or increases.
With the muscle-fat ratio corrected, continue Mounjaro with dose adjustments as needed. Introduce advanced health testing: methylation analysis for personalised nutrition, GlycanAge for biological ageing. Comprehensive blood panel to assess improvements. Build your personalised health dashboard with full biomarker tracking. Metabolic age should start dropping as muscle is preserved.
Reach target weight zone (67–70 kg). Metabolic age should be at or below chronological age. Full health dashboard populated with bloods, body composition trends, genetics insights, personalised nutrition and exercise plans, sleep optimisation, and stress management. Transition from weight loss to long-term health maintenance and optimisation.
Based on our clinical analysis of your three body composition scans, your medical history, and current evidence in longevity medicine, here is the strategy DoctoriumGP recommends to protect your muscle, accelerate fat loss, and reduce your biological age. Every recommendation below is backed by peer-reviewed research and tailored specifically to your profile.
Mounjaro is clearly working for your weight loss, and we want you to continue with it. However, clinical evidence shows that without specific countermeasures, up to 30–40% of weight lost on GLP-1 medications can be lean muscle mass rather than fat. Your scan data shows this pattern has already begun — 63% of your latest weight loss was muscle.
This is exactly why DoctoriumGP monitors body composition rather than just weight, and why we provide doctor-supervised GLP-1 programmes rather than just prescribing medication. The protocol to protect your muscle while on Mounjaro is:
If you'd only stepped on the scales, you'd see 3.8 kg lost and feel great. And you should feel positive — that weight loss is real progress. But this scan reveals what the scales can't: of that 3.8 kg, 2.4 kg was muscle and only 1.2 kg was fat. Without this scan data, you'd have no idea that your metabolic age actually got worse despite losing weight.
This is exactly the "GLP-1 trap" we discussed in your first report. It's not a failure — it's a common pattern that we now catch early because we're monitoring properly. The fix is straightforward: structured resistance training and higher protein intake. Many clients who make this adjustment see their muscle stabilise within 4–6 weeks while fat loss continues.
This is why body composition scanning is so much more valuable than just weighing yourself. And it's why the methylation and blood testing matters — it gives us the detailed nutritional roadmap to protect your muscle, bones and metabolic rate while the weight comes off.
This body composition analysis is just the starting point. We're building a comprehensive health intelligence platform for our clients that brings together all of your health data in one place — giving you a complete picture of your health and a clear roadmap to optimise it.